Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michael V W, Bergamini"'
Autor:
Brigitte Duquesroix, Elena Bastia, Stefania Brambilla, Nicoletta Almirante, Francesco Impagnatiello, Michael V W Bergamini, Angela C. Kothe
In patients with ocular hypertension or glaucoma, all treatments aim to lower intraocular pressure (IOP) by modulating aqueous humour (AH) production and/or uveoscleral and trabecular meshwork/Schlemm's canal AH drainage. PG analogues are considered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9475fc1160cda828d2eb15c7737d1e2
https://europepmc.org/articles/PMC6451067/
https://europepmc.org/articles/PMC6451067/
Autor:
Jaime E. Dickerson, Russell M. Andrew, Lewis H. Silver, Theresa A. Landry, E. Kenneth Sullivan, Alberta A Davis, Michael V. W. Bergamini, Peter A. Netland, Alan L. Weiner, Sushanta Mallick, Stella M. Robertson
Publikováno v:
American Journal of Ophthalmology. 132:472-484
● PURPOSE: This study evaluated the safety and intraocular pressure–lowering efficacy of two concentrations of travoprost (0.0015% and 0.004%) compared with latanoprost 0.005% and timolol 0.5% in patients with open-angle glaucoma or ocular hypert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0826d79c3b67782df4228fe0c127e70
https://doi.org/10.1016/s0002-9394(01)01177-1
https://doi.org/10.1016/s0002-9394(01)01177-1
Autor:
Ronald L, Gross, E Kenneth, Sullivan, David T, Wells, Sushanta, Mallick, Theresa A, Landry, Michael V W, Bergamini
Publikováno v:
Clinical ophthalmology (Auckland, N.Z.)
Purpose: To compare the IOP-lowering efficacy of the fixed combination of travoprost 0.004%/timolol 0.5% dosed once daily in the morning with the concomitant administration of travoprost 0.004% dosed once daily in the evening and timolol 0.5% dosed o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64b0bf64f456877c706f0952256910f5
https://pubmed.ncbi.nlm.nih.gov/19668487
https://pubmed.ncbi.nlm.nih.gov/19668487
Autor:
Martin, Kaback, Stephen V, Scoper, George, Arzeno, John E, James, Steven Y, Hua, Craig, Salem, Jaime E, Dickerson, Theresa A, Landry, Michael V W, Bergamini, Thomas R, Walters
Publikováno v:
Ophthalmology. 115:1728-1734.e2
Purpose To compare the safety and intraocular pressure (IOP)-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination with brinzolamide 1% or timolol 0.5% alone in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0629ad5943700c4bc3fb7c503c596fda
https://doi.org/10.1016/j.ophtha.2008.04.011
https://doi.org/10.1016/j.ophtha.2008.04.011
Publikováno v:
Archives of Ophthalmology. 98:1102-1105
• Following the suggestion that prostaglandins are involved in corneal neovascularization, two inhibitors of prostaglandin formation, prednisolone acetate and flurbiprofen sodium, have been evaluated in two experimental models of corneal neovascula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d0586b4cc676e97236a3cfa076eb1f
https://doi.org/10.1001/archopht.1980.01020031092017
https://doi.org/10.1001/archopht.1980.01020031092017
Publikováno v:
Archives of Ophthalmology. 99:681
• Flurbiprofen is a nonsteroidal anti-inflammatory (NSAI) agent currently undergoing clinical investigation. Anti-inflammatory steroids have long been known to delay the healing of corneal stromal wounds. This study was designed to compare the effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d659a5bffdb0bc7b68860cec1aeaf1
https://doi.org/10.1001/archopht.1981.03930010681016
https://doi.org/10.1001/archopht.1981.03930010681016